About the journal
Cancers is an open-access journal published by Multidisciplinary Digital Publishing Institute in Switzerland. It is listed in PUBMED according to the sources read. Declared publication charge: 2,598 CHF. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Multidisciplinary Digital Publishing Institute
- ISSN
- 2072-6694
- Country
- Switzerland
- Access
- Open access
- Declared publication charge
- 2,598 CHF
- Official website
- https://www.mdpi.com/journal/cancers/
Index listings
- PUBMED · 2009-11-18
- Indexing
- PUBMED
- APC
- 2,598 CHF
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
36759
Last recorded publication year
2026
h-index
220
i10-index
20146
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 95%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101526829
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
Show all subjects (50)
- Radiomics and Machine Learning in Medical Imaging
- Glioma Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Glioma Diagnosis and Treatment
- Cancer, Hypoxia, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Hepatocellular Carcinoma Treatment and Prognosis
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- CAR-T cell therapy research
- CAR-T cell therapy research
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Cancer-related molecular mechanisms research
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- MicroRNA in disease regulation
- Lung Cancer Research Studies
- RNA modifications and cancer
- RNA modifications and cancer
- Lung Cancer Research Studies
- Head and Neck Cancer Studies
- Head and Neck Cancer Studies
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Immune cells in cancer
- Lung Cancer Diagnosis and Treatment
- Immune cells in cancer
- Ovarian cancer diagnosis and treatment
- Ferroptosis and cancer prognosis
- Ovarian cancer diagnosis and treatment
- Ferroptosis and cancer prognosis
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ